Iimpawu zoMsebenzi
Umda wokufumanisa: 5.0 mg / L ;
Uluhlu lomgca: 5 ~ 200 mg / L;
I-coefficient yokulungelelanisa yomgca R ≥ 0.990;
Ukuchaneka: ngaphakathi kwe-batch CV ngu ≤ 15%;phakathi kweebhetshi iCV yi ≤ 20%;
Ukuchaneka: ukutenxa okunxulumene neziphumo zomlinganiselo akusayi kudlula ±I-15% xa i-calibrator yokuchaneka elungiselelwe ngumgangatho wesizwe we-MAU okanye i-standard standardized accuracy calibrator ivavanywa.
1. Gcina i-detector buffer ku-2~30℃.Isithinteli sizinzile ukuya kwiinyanga ezili-18.
2. Gcina i-Aehealth NGAL Rapid Quantitative test cassette kwi-2~30℃, ubomi beshelufu bufikelela kwiinyanga ezili-18.
3. Ikhasethi yovavanyo kufuneka isetyenziswe kwiyure enye emva kokuvula ipakethi.
Ukuvela kwe-urine microalbumin (MAU) kuphawu lokuqala lomonakalo wezintso.Kwiimeko eziqhelekileyo, iprotheni eninzi ayinakudlula iiprotheni ze-membrane zokuhluza, nangona kunjalo, kwiimeko ze-pathological (umzekelo: ukuvuvukala, ukuphazamiseka kwe-metabolic kunye nomonakalo we-immune), i-glomerular ibe yi-hemodynamic abnormalities.IGlomerular filtration in membrane umonakalo sisizathu esibalulekileyo sokwanda kwe-microalbumin yomchamo.